This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Sleep Apnea Diagnostic And Therapeutic Devices Industry

Reimbursement Criteria for Sleep Apnea Diagnostic and

Therapy Devices III-4

Table 39: Reimbursement Rates of CPAP Devices: 2010 (In

US$) III-5

Average Replacement Schedules III-6

Competitive Landscape III-6

Table 40: US Market for Sleep Therapy (2011) - Percentage

Breakdown of Revenues for Respironics, ResMed, Fisher &

Paykel, and Others III-6

Distribution of Sleep Apnea Devices III-6

A Review of the Sleep Service Providers Market III-7

Greater Awareness Drives More Number of Sleep Labs III-7

Table 41: Increasing Number of Sleep Facilities in the US

(includes corresponding Graph/Chart) III-7

Changeover of the Sleep Lab III-8

Inadequate Sleep Labs - a Bottleneck for Diagnosis of OSA III-8

Inadequate Sleep Labs Surge Development of Portable Sleep

Monitoring III-8

DME Market for Sleep Apnea Devices III-9

Table 42: US Market for CPAP Devices (2010) - Percentage

Breakdown of Value Sales by Durable Medical Equipment (DME)

Suppliers for Apria Healthcare Group, Lincare Holdings Inc,

National Companies and Local Operators (includes

corresponding Graph/Chart) III-9

Strategic Corporate Developments III-9

Focus on Select Players III-13

B.Market Analytics III-18

Table 43: The US Recent Past, Current & Future Analysis for

Sleep Apnea Diagnostic and Therapeutic Devices by Product

Segment - Diagnostic Devices (Clinical/Fixed PSG, Ambulatory

PSG, and Others (Screening Devices)), and Therapeutic

Devices (CPAP, Auto PAP, Bi-Level PAP, and Facial Interfaces

(Masks and Humidifiers)) Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-18

Table 44: The US Historic Review for Sleep Apnea Diagnosticand Therapeutic Devices by Product Segment - DiagnosticDevices (Clinical/Fixed PSG, Ambulatory PSG, and Others(Screening Devices)), and Therapeutic Devices (CPAP ,AutoPAP, Bi-Level PAP, and Facial Interfaces (Masks andHumidifiers)) Markets Independently Analyzed with AnnualSales in US$ Million for Years 2004 through 2009 (includescorresponding Graph/Chart) III-19

Table 45: The US 15-Year Perspective for Sleep Apnea

Diagnostic and Therapeutic Devices by Product Segment -

10 of 16

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs